Cyclic AMP (cAMP) is involved in the stress response in Saccharomyces cerevisiae. We show that cAMP is required for resistance to fluconazole in S. cerevisiae. In addition, activation of Ras2, a regulator of cAMP generation, results in some protection from fluconazole toxicity in a fashion independent of the efflux transporter Pdr5p.
1 and 34 Ϯ 1 mm respectively [ Table 1 ]). The plates were grown at 30°C for 24 h. Experiments were done in triplicate at different time points. These results could be interpreted as evidence that cAMP is required for activation of response mechanisms to protect the cell from fluconazole. The lack of a significantly increased resistance in the wild type by increased amounts of exogenous cAMP can be explained by the known resistance of wild-type strains to external cAMP and by the high internal levels of cAMP in wild-type cells (11) .
Expression of RAS2
Val19 results in resistance to fluconazole in a PDR5-independent fashion. RAS2
Val19 is a well-characterized dominant active allele of RAS2 (10 , the resulting strains were inoculated in 5 ml of liquid SC-uracil medium. Cultures were grown to saturation at 30°C, diluted (1:1,000) in 10 ml of SC-uracil medium, and grown at 30°C into late log phase. Yeast growth was examined by spreading approximately 10 5 cells of each culture on SC-uracil plates containing 100 g of fluconazole in a paper disk. Growth on plates at 30°C was evaluated for 24 h. Experiments were performed in triplicate at different time points. As shown in Table 1 Val19 strains respectively (ZI, 52 Ϯ 1 mm in DK13-5D; ZI, 44 Ϯ 2 mm in DK13-5D/Ras2
Val19 ). The observed small protective effect in strains expressing Ras2
Val19 was not specific to fluconazole, because protection from cycloheximide (5 g in a paper disk) was also seen in these strains on SC-uracil plates. On the other hand, toxicity from 5-fluorocytosine (50 g in a paper disk) was no different in the strains expressing Ras2
Val19
(data not shown). Cycloheximide but not 5-fluorouracil is a substrate of Pdr5p (2) .
In conclusion, our data suggest that cAMP is required for resistance to fluconazole. This is in agreement with our finding that the activation of the Ras pathway exerts some protective effect against fluconazole toxicity in Saccharomyces. The exact mechanism of protection is not known. However, cAMP and the Ras pathway may regulate either directly or indirectly the major facilitator superfamily network of transporters and thus the efficiency of drug efflux in Saccharomyces. This hypothesis is supported by the finding that CDC25, an upstream regulator of RAS2, affects the activity of the major facilitator superfamily glucose transporters (9) . Elucidation of the role of cAMP in azole resistance could shed light on the mechanisms of resistance of the inherently resistant pathogenic fungi. 44 Ϯ 2 a Resistance tested using 100 g of fluconazole by applying 20 l of a 5-mg/ml fluconazole solution in sterile water to a paper disk. All experiments were performed in triplicate.
b Approximately 10 5 cells were spread on SC plates, and growth was examined after 24 h at 30°C.
c Approximately 10 5 cells were spread on SC-uracil plates, and growth was examined after 24 h at 30°C.
